Epidemiology of major respiratory pathogens

Journal of Chemotherapy

Volumn 13, Issue SPEC. ISS. 1, 2001, Pages 205-210

  Debbia, Eugenio A ^a   Schito, G C ^a   Zoratti, A ^a   Gualco, L ^a   Tonoli, E ^a   Marchese, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Antibiotic resistance; Haemophilus influenzae; Moraxella catarrhalis; Respiratory pathogens; Streptococcus pneumoniae

Indexed keywords

AMIKACIN; AMINOPENICILLIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; MACROLIDE; NETILMICIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CONFERENCE PAPER; ENZYME SYNTHESIS; EUROPE; FRANCE; GEOGRAPHIC DISTRIBUTION; GERMANY; HAEMOPHILUS INFLUENZAE; HUMAN; INCIDENCE; ITALY; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NETHERLANDS; NONHUMAN; PENICILLIN RESISTANCE; RESPIRATORY TRACT INFECTION; SCANDINAVIA; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 0035721669     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2001.13.supplement-2.205     Document Type: Conference Paper

References (41)

1. The challenges of emerging infectious diseases
2. World Health Organization strategy for emerging infectious diseases
3. Resistance to antibiotics
4. Inactivation of antibiotics and the dissemination of resistance genes
5. Introduction: Problems with antimicrobial resistance in Gram-positive cocci
6. Evolution and spread of SHV extended-spectrum β-lactamases in Gram-negative bacteria
7. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit
8. Consequence of bacterial resistance to antibiotics in medical practice
9. The management of infections and antibiotic therapy: A European survey
10. Antibiotic treatment of community-acquired pneumonia in clinical practice: A European perspective
11. The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally
12. Surveillance of antimicrobial resistance: The WHONET Program
13. Decreased in antibiotic susceptibiltiy or increase in resistance?
14. A multicenter collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander Project
15. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens: Findings of the Alexander Project 1992-1996
16. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 Results from the SENTRY antimicrobial surveillance program
17. Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997)
18. International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada and South America for the SENTRY program
19. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: Antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997)
20. Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme
21. Prevalence of aminoglycoside resistance in 20 European University Hospitals participating in the European SENTRY antimicrobial surveillance programme
22. National Nosocomial Infections Surveillance (NNIS) system: Description of surveillance methods
23. Nosocomial infection rates in adult and paediatric intensive care units in the United States
24. Nosocomial bloodstream infections in the SCOPE Program: Antimicrobial resistance, species occurrence, molecular testing results and laboratory testing accuracy
25. Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: Frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE Program
26. Inducible Amp C β-lactamase producing Gram-negative bacilli from bloodstream infections: Frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE)
27. New group tracks hospital's drug-resistant bugs
28. SIREVA: Surveillance of invasive Streptococcus pneumoniae in Brazil (1993-1998): Molecular characterization of penicillin-resistant strains
29. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian network for Surveillance of resistant pathogens (ANSORP) study
30. The prevalence of nosocomial infection in intensive care units in Europe
31. Surveillance of the current resistance of nosocomial pathogens to antibacterials
32. Epidemiologia dei microorganismi gram-negativi e gram-positivi isolati nel 1997 in un grande nosocomio e valutazione della sensibilità agli antibiotici di P. aeruginosa
33. Nosocomial respiratory infection
34. Pneumococcal resistance patterns in Europe
35. Is the use of narrow-spectrum antibiotics too narrow-minded in the treatment of severe infections?
36. Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs)
37. La chemioterapia antimicrobica nelle unità di terapia intensiva in Italia
38. Beta-lactamase-mediated resistance and opportunities for its control
39. Beta-lactams mode of action and mechanism of bacterial resistance
40. Detection of SHV-5 Extended-Spectrum β-lactamase SHV-5 in Klebsiella pneumoniae strains isolated in Italy
41. Sensibilità agli antibiotici di ceppi di enterobacteriaceae e staphylococcus aureus isolati dalle vie respiratorie nel 1997 e nel 1998